Accelerate Diagnostics: 3Q Earnings Snapshot

November 6, 2018

TUCSON, Ariz. (AP) _ Accelerate Diagnostics Inc. (AXDX) on Tuesday reported a loss of $22.1 million in its third quarter.

On a per-share basis, the Tucson, Arizona-based company said it had a loss of 41 cents.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 44 cents per share.

The maker of systems that diagnose drug-resistant infections posted revenue of $1.4 million in the period, which fell short of Street forecasts. Three analysts surveyed by Zacks expected $2.9 million.

Accelerate Diagnostics shares have declined 38 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $16.30, a decline of 16 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AXDX at https://www.zacks.com/ap/AXDX

Update hourly